AJTMH ASTMH Job Mart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am. J. Trop. Med. Hyg., 21(5_Suppl), 1972, pp. 744-748
Copyright © 1972 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Powell, R. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Powell, R. D.

Development of New Antimalarial Drugs

Robin D. Powell
Department of Internal Medicine, College of Medicine, University of Iowa, and Veterans Administration Hospital, Iowa City, Iowa 52240

Strains of Plasmodium falciparum that are resistant to chloroquine and to other widely-used synthetic antimalarial drugs have posed major difficulties in several parts of the world. Intensive efforts have been and are being made to develop new antimalarial agents that will be effective against such parasites. Several promising prospective new antimalarial agents have been identified and are now undergoing detailed clinical evaluation. The advent of one or two useful new agents should not serve as a source of renewed complacency. Parasites resistant to the latter agents may emerge and may limit their usefulness. Other new antimalarial drugs may be needed as backstops. There is and will be a continuing need to wage a strong investigative attack not only to develop new antimalarial drugs but also to develop other improved means with which to combat malaria.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1972 by the American Society of Tropical Medicine and Hygiene.